rs11210074 - LINC02796: listeria peptide association
Upload your raw genetic data once, we'll show you which variants you carry and what the research says.
Key takeaways
- This SNP is linked to seropositivity for the listeria phage list-32 peptide
- The effect size reported is 5.62 with p=2e-8 in about 1000 participants
- The association was found in a genome-wide association study
Key takeaways
- This SNP is linked to seropositivity for the listeria phage list-32 peptide
- The effect size reported is 5.62 with p=2e-8 in about 1 thousand individuals
- The association was found in a genome-wide association study
What the research says This variant is linked to seropositivity for the listeria phage list-32 peptide [PMID 37164013]. The reported effect size is 5.62 with p=2e-8 in about 1 thousand individuals [PMID 37164013].
Reported associations
- Seropositivity for listeria phage list-32 peptide: the variant increases detection of this bacterial peptide with a reported effect size of 5.62 p=2e-8 in about 1 thousand individuals [PMID 37164013]
Evidence quality The evidence comes from a single GWAS catalog association with effect size 5.62 p=2e-8 in about 1 thousand individuals [PMID 37164013]. No other studies were provided, so the finding is not replicated.
Tissue-specific expression effects
- LINC02796: increased expression in brain nucleus accumbens basal ganglia GTEx Portal
- LINC01360: reduced expression in testis GTEx Portal
No lifestyle considerations on file for this variant.
Frequently asked questions
What does rs11210074 mean?
It is a genetic variant at the LINC02796 locus that has been associated with higher detection of a specific bacterial peptide. The effect size is 5.62 p=2e-8 in about 1000 people.
Is this SNP related to disease?
No, it is not linked to any known disease; the association is only with the presence of the listeria phage list-32 peptide.
Can I test for this variant?
The variant can be identified in DNA analysis but there are no clinical tests that use it for diagnosis or treatment.